Nano Based Approach for the Neurological Disorder Treatments-A Scenario (A-Review)
-
Published:2023-04-30
Issue:2
Volume:39
Page:263-275
-
ISSN:2231-5039
-
Container-title:Oriental Journal Of Chemistry
-
language:en
-
Short-container-title:Orient. J. Chem
Author:
Oli Ajay Kumar1ORCID, Jain Apoorva1ORCID, Shivshetty Nagaveni2ORCID, Javaregowda Palaksha Kanive1ORCID, Chandrakanth. Kelmani3ORCID
Affiliation:
1. 1Department of Biomedical Science, SDM Research Institute for Biomedical Sciences,Shri Dharmasthala Manjunatheshwara University, 5th Floor, Manjushree Building, SDM College of Medical Sciences and Hospital Campus, Sattur, Dharwad, Karnataka-India. 2. 2Department of Microbiology/ Food Science and Technology, GITAM Institute of Science, GITAM (Deemed to be University), Gandhi Nagar, Rushikonda, Visakhapatnam-530045, Andhra Pradesh- India. 3. 3Department of Biotechnology, Jnana Ganga Campus, Gulbarga University, Kalaburagi- 585106, Karnataka-India.
Abstract
The prevalence of neurological illnesses is a leading cause of mortality and disability is rising globally. It is the second greatest cause of death globally. Multiple years of life adjusted for incidence of death and disability (DALY), the sum of years of life lost (YLLs) and years lived with disability (YLDs) by age and sex, are used to classify 15 neurological illnesses. Alzheimer's, Parkinson's, a stroke, Huntington's disease, and epilepsy are a few of them. Therefore, it is crucial to design and create novel delivery systems that could transport the therapeutic medications or diagnostic tools needed to treat neurological illnesses. In this overview, we go through fresh methods for improving medication absorption by the central nervous system (CNS). The treatment of neurological diseases, particularly those with neurodegenerative features, has a significant deal of potential to be impacted by nanotechnology. According to a number of studies, neurodegenerative CNS illnesses have been successfully treated with nanomaterials. The most effective usage of nanomaterials is the treatment of CNS disorders, which improves the overall impact of the medication and highlights the significance of nanotherapeutics.
Publisher
Oriental Scientific Publishing Company
Subject
Drug Discovery,Environmental Chemistry,Biochemistry,General Chemistry
Reference98 articles.
1. 1. Simonato, M.; Bennett, J.; Boulis, N.M.; Castro, M.G.; Fink, D.J.; Goins, W.F.; Gray, S.J.; Lowenstein, P.R.; Vandenberghe, L.H.; Wilson, T.J.; Wolfe, J.H.; Glorioso, J.C. Nature Reviews Neurology. 2013, 9, 277-291. 2. 2. Maha, Z.R.; Ghadha, I.F.; Hanan, F.A. Neurological Disorders: causes and Treatment strategies. International Journal of Public Mental Health and Neurosciences. 2018, 5(1), 32-40. 3. 3. Tinkle, S.; Mcneil, S.E.; Muhlebach, S.; Bawa, R.; Borchard, G.; Barnholz, Y.C.; Tamarkin, T.; Desai, N. Nanomedicines: addressing the scientific and regulatory gap. Ann N Y Acad Sci. 2014. 1313, 35-56. 4. 4. Bleeker, E.A.; deJong, W.H.; Geertsma, R.E.; Groenewold, M.; Heugens, E.H.; Koers-Jacquemijins. M.; Meent D.V.; Ropma J.R.; Rietvel, A.G.; Wijnhoven W.P.S.; Cassee, R.G.; Oomen G.A. Considerations on the EU definition of a nanomaterial: science to support policy making. Regul Toxicol Pharmacol. 2013, 65,119-125. 5. 5. Ossa, C.; Ma, Y.C.; Wang, Z.X. Structure-activity relationship models for hazard assessment and risk management of engineered nanomaterials. Proc. Eng. 2014, 102,1500-1510.
|
|